Weight Management

Wegovy is a prescription medication used for weight loss, specifically licensed in the UK for this purpose since 2023. It contains the active ingredient semaglutide, a hormone that mimics the natural hormone GLP-1 (glucagon-like peptide-1). GLP-1 is involved in regulating blood sugar levels and appetite. By mimicking this hormone, Wegovy helps reduce appetite, leading to lower calorie intake and subsequent weight loss.

Key Points About Wegovy:

• Form: Wegovy is administered as a weekly injection via a pre-filled pen.
• Dosing: It comes in various dosages, including 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, with the dosage typically increasing over time under medical supervision.
• Uses: While semaglutide (the active ingredient) is also used to treat type 2 diabetes under different brand names (like Ozempic), Wegovy is specifically licensed for weight loss in adults and adolescents aged 12 and over with a high BMI.
• Eligibility: Adults with a BMI over 30 or those with a BMI over 27 who also have weight-related health issues (e.g., high blood pressure, type 2 diabetes) are eligible. Children aged 12 and over with obesity (BMI at the 95th percentile or greater) can also use it when combined with a reduced-calorie diet and increased physical activity.
• Side Effects: Common side effects include gastrointestinal issues like nausea, diarrhea, and constipation. Serious side effects may include thyroid tumors and allergic reactions. It’s not suitable for individuals with certain medical conditions, such as a history of thyroid cancer or pancreatitis.

Wegovy has shown effectiveness in clinical trials, with an average weight reduction of around 15% in participants. However, its use must be closely monitored by healthcare professionals, particularly due to the potential side effects and the need for proper dosage management.

The prices listed for Wegovy pens vary depending on the dosage:

• 0.25 mg Pen: £137.99
• 0.5 mg Pen: £137.99
• 1 mg Pen: £148.99
• 1.7 mg Pen: £219.99
• 2.4 mg Pen: £253.99